• The Chairman of the Authority follows up with the Chairman of Novartis Egypt on indicators of implementing the Memorandum of Understanding to enhance the care of oncology patients and expand cooperation in the fields of cardiology
• Chairman of the Authority:
- Discussing cooperation with Novartis to transform the Aswan Oncology Center into an advanced regional and research center. He invites the company to visit the institute to support partnership avenues
- Discussing strengthening cooperation with Novartis to train doctors on the latest heart and breast tumor treatments and to enhance the periodic updating of treatment protocols. Doubling the number of doctors benefiting from training in these specialties
- Discussing the launch of an accredited electronic training platform in cooperation with Novartis to qualify family doctors for non-communicable diseases and develop innovative solutions to enhance patient awareness and medical follow-up
We renew our commitment to strengthening cooperation with the Authority to expand the scope of initiatives in early detection and treatment of patients with tumors, heart disease, and noncommunicable diseases
..........................
Dr. Ahmed El-Sobky, Chairman of the Authority, met with Dr. Jihan El-Murr, Chairman of the Board of Directors of Novartis Egypt and Managing Director, to follow up on indicators for implementing the memorandum of understanding signed between the two sides last February, which aims to enhance the care of oncology patients, expand horizons of cooperation in the fields of cardiology, and develop medical training.
The meeting discussed the latest indicators for implementing the provisions of the Memorandum of Understanding and the outcomes of joint work. It also discussed enhancing cooperation in supporting the treatment of cancer patients and updating treatment protocols for heart diseases, in addition to expanding the scope of partnership in the areas of training, awareness, and prevention, in line with Egypt's Vision 2030.
During the meeting, Dr. Ahmed El-Sobky stressed that the Authority seeks to transform the Aswan Oncology Center into an advanced regional and research center for oncology treatment, in cooperation with international partners, including Novartis, in a way that enhances the center's role in providing advanced treatment services and supporting scientific research in this vital specialty. He extended an official invitation to company officials to visit the Aswan Medical Center to study ways to support partnership and joint cooperation on the ground.
This enhances the center's role in providing advanced therapeutic services and supporting scientific research in this vital specialty. He extended an official invitation to company officials to visit the Aswan Medical Center to study ways to support partnership and joint cooperation on the ground.
The meeting also discussed ways to enhance cooperation in training doctors on the latest scientific findings in treatments for heart diseases and breast tumors, as part of the Authority's plans to update treatment protocols periodically, ensuring the provision of the best means of health care to patients. Al-Sobki stressed the importance of doubling the number of doctors benefiting from training programs in cooperation with Novartis, to expand the impact of professional development on the level of health service provision.
The meeting discussed mechanisms for launching an accredited electronic training platform in cooperation between the Authority and Novartis, to qualify family doctors to manage non-communicable diseases, such as high blood pressure, diabetes, and chronic heart disease. The two sides also discussed developing innovative solutions to enhance health awareness, ensure continuous medical follow-up of patients, and achieve a more efficient and sustainable healthcare experience.
For her part, Dr. Jihan Al-Murr, Chairman of the Board of Directors of Novartis Egypt, expressed her pride in the growing partnership with the General Authority for Health Care, praising the successes achieved on the ground, and stressing the company's commitment to expanding the scope of cooperation, especially in the fields of early detection and treatment of cancer patients, heart diseases, and noncommunicable diseases. She also noted that every joint initiative with the Authority yields tangible results that contribute to improving patients' quality of life and supporting the health system.
The meeting was attended by Novartis Egypt: Dr. Rania Ashraf, Head of Novartis Middle East and Africa External Relations Sector, Dr. Amr Nasr, Head of Novartis Egypt External Relations Sector, and Dr. Abdel Aziz Ahmed, Head of Market Access Sector.
Also present from the General Authority for Health Care were: Dr. Hani Rashid, Vice Chairman of the Authority's Board of Directors, Dr. Farid Muharram, Member of the Authority's Board of Directors and Dean of the Faculty of Commerce at Ain Shams University, Dr. Amir Al-Talwani, Executive Director of the Authority, Dr. Ahmed Hammad, Advisor to the Chairman of the Authority for Health Policies and Systems and Director General of the General Administration of Strategic Management, Dr. Wael Omran, Advisor to the Chairman of the Authority for Supply Affairs and Director General of the General Administration for Administrative Affairs, Dr. Mahmoud El-Deeb Assistant Executive Director for Health Planning and Mapping Affairs and Director General of the Technical Office of the Chairman of the Authority, Dr. Heba Awida, Director General of the General Administration of Research and Development, Dr. Radwa Imam, Deputy Director General of the General Administration of Primary Care for Population Health, Director of the Family Medicine Centers Department and Supervisor of the Health Initiatives and Awareness Unit, and Dr. Maha Saeed, Director of the Pharmacovigilance Unit.
